Takeda Pharmaceutical Company Limited (TAK) Free Cash Flow by Year
Takeda Pharmaceutical Company Limited generated $5.7B in free cash flow in fiscal year 2025. This represents an increase of 59.7% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Takeda Pharmaceutical Company Limited has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TAK Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TAK Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Takeda Pharmaceutical Company Limited financials
Frequently Asked Questions
What was Takeda Pharmaceutical Company Limited's free cash flow in fiscal year 2025?
Takeda Pharmaceutical Company Limited generated $5.7B in free cash flow in fiscal year 2025.
How fast is Takeda Pharmaceutical Company Limited's free cash flow growing?
Takeda Pharmaceutical Company Limited (TAK) free cash flow rose by 59.7% year over year, from $3.6B to $5.7B in fiscal year 2025.
How has Takeda Pharmaceutical Company Limited's free cash flow changed over the years?
Across the 9 fiscal years this page covers, Takeda Pharmaceutical Company Limited (TAK) free cash flow went from $1.8B in fiscal year 2017 to $5.7B in fiscal year 2025.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Takeda Pharmaceutical Company Limited (TAK) reported on that line in every period on record.